CytoAgents is Drug Discovery in United States that focus on respiratory epidemics business. Founded in 2018. They cover business area such as developer, innovative pharmaceutical drug, cytokine release syndrome, multiple indication, high unmet need, oncology CAR-T cell therapy, respiratory epidemic, physician, effectively patient, CRS.
2018
( 8 years old in 2026 )
Respiratory Epidemics
-
100 South Commons
Suite 102
Pittsburgh, PA 15212
United States
Private
developerinnovative pharmaceutical drugcytokine release syndromemultiple indicationhigh unmet needoncology CAR-T cell therapyrespiratory epidemicphysicianeffectively patientCRS
* We use standard office opening hours in near CytoAgents's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
CytoAgents is Drug Discovery business from United States that founded in 2018 (8 years old in 2026), CytoAgents business is focusing on Respiratory Epidemics.
CytoAgents headquarter office and corporate office address is located in 100 South Commons Suite 102 Pittsburgh, PA 15212 United States.
CytoAgents was founded in United States.
In 2026, CytoAgents is currently focus on respiratory epidemics sector.
Above is snippet of Google Trends for "respiratory epidemics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with CytoAgents, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
